AI-generated summary
This randomized, sham-controlled trial of 50 patients with painful diabetic sensorimotor polyneuropathy compared low-intensity laser therapy with sham treatment. The authors report an additional pain reduction in the laser group that did not reach statistical significance (P = 0.07), with no effect on nerve or sensory measures, and conclude the evidence is insufficient to recommend the treatment.
- Participants
- 50
- Who or what was studied
- Patients with painful diabetic sensorimotor polyneuropathy diagnosed with the Toronto Clinical Neuropathy Score
- Limits stated in the abstract
- The between-group difference did not reach statistical significance (P = 0.07), and the authors state the results do not provide sufficient evidence to recommend the treatment.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on diabetesjournals.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Sham, Neuropathy, Visual analogue scale. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.